This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| bacteria:t3e:xopq [2025/02/13 12:47] – jfpothier | bacteria:t3e:xopq [2025/11/24 14:24] (current) – jfpothier | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| ====== The Type III Effector XopQ from // | ====== The Type III Effector XopQ from // | ||
| - | Author: Valérie Olivier | + | Author: Valérie Olivier, [[https:// |
| - | Internal reviewer: [[https:// | + | Internal reviewer: [[https:// |
| Class: XopQ\\ | Class: XopQ\\ | ||
| Line 16: | Line 16: | ||
| XopQ was identified in a genetic screen, using a Tn// | XopQ was identified in a genetic screen, using a Tn// | ||
| + | |||
| === (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
| Type III-dependent secretion was confirmed using a calmodulin-dependent adenylate cyclase reporter assay, with a Δ//hrpF// mutant strain serving as negative control (Roden //et al//., 2004). Using an AvrBs1 reporter fusion, XopQ< | Type III-dependent secretion was confirmed using a calmodulin-dependent adenylate cyclase reporter assay, with a Δ//hrpF// mutant strain serving as negative control (Roden //et al//., 2004). Using an AvrBs1 reporter fusion, XopQ< | ||
| + | |||
| === Regulation === | === Regulation === | ||
| Line 24: | Line 26: | ||
| qRT-PCR revealed that transcript levels of 15 out of 18 tested non-TAL effector genes (as well as the regulatory genes //hrpG// and //hrpX//) were significantly reduced in the // | qRT-PCR revealed that transcript levels of 15 out of 18 tested non-TAL effector genes (as well as the regulatory genes //hrpG// and //hrpX//) were significantly reduced in the // | ||
| + | |||
| === Phenotypes === | === Phenotypes === | ||